These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35066183)

  • 1. Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction.
    Stacy MR; Lin BA; Thorn SL; Lobb DC; Maxfield MW; Novack C; Zellars KN; Freeburg L; Akar JG; Sinusas AJ; Spinale FG
    Heart Rhythm; 2022 May; 19(5):847-855. PubMed ID: 35066183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
    Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
    Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant activation of gene promoters for matrix metalloproteinases and tissue inhibitors of the metalloproteinases following myocardial infarction.
    Mukherjee R; Snipes JM; Saunders SM; Zavadzkas JA; Spinale FG
    J Surg Res; 2012 Jan; 172(1):59-67. PubMed ID: 20863528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
    Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Hybrid Matrix Metalloproteinase-Targeted and Dynamic
    Thorn SL; Barlow SC; Feher A; Stacy MR; Doviak H; Jacobs J; Zellars K; Renaud JM; Klein R; deKemp RA; Khakoo AY; Lee T; Spinale FG; Sinusas AJ
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009055. PubMed ID: 31707811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.
    Dixon JA; Gorman RC; Stroud RE; Mukherjee R; Meyer EC; Baker NL; Morita M; Hamamoto H; Ryan LP; Gorman JH; Spinale FG
    Circulation; 2011 Sep; 124(11 Suppl):S35-45. PubMed ID: 21911817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
    Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
    Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term localized high-frequency electric stimulation within the myocardial infarct: effects on matrix metalloproteinases and regional remodeling.
    Mukherjee R; Rivers WT; Ruddy JM; Matthews RG; Koval CN; Plyler RA; Chang EI; Patel RK; Kern CB; Stroud RE; Spinale FG
    Circulation; 2010 Jul; 122(1):20-32. PubMed ID: 20566951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.
    Sahul ZH; Mukherjee R; Song J; McAteer J; Stroud RE; Dione DP; Staib L; Papademetris X; Dobrucki LW; Duncan JS; Spinale FG; Sinusas AJ
    Circ Cardiovasc Imaging; 2011 Jul; 4(4):381-91. PubMed ID: 21505092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.
    Wilson EM; Moainie SL; Baskin JM; Lowry AS; Deschamps AM; Mukherjee R; Guy TS; St John-Sutton MG; Gorman JH; Edmunds LH; Gorman RC; Spinale FG
    Circulation; 2003 Jun; 107(22):2857-63. PubMed ID: 12771000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.
    Lobb DC; Doviak H; Brower GL; Romito E; O'Neill JW; Smith S; Shuman JA; Freels PD; Zellars KN; Freeburg LA; Khakoo AY; Lee T; Spinale FG
    J Pharmacol Exp Ther; 2020 Nov; 375(2):296-307. PubMed ID: 32958629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.
    Kandalam V; Basu R; Abraham T; Wang X; Awad A; Wang W; Lopaschuk GD; Maeda N; Oudit GY; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1012-23. PubMed ID: 20675565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition.
    Ikonomidis JS; Hendrick JW; Parkhurst AM; Herron AR; Escobar PG; Dowdy KB; Stroud RE; Hapke E; Zile MR; Spinale FG
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H149-58. PubMed ID: 15598866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.
    Webb CS; Bonnema DD; Ahmed SH; Leonardi AH; McClure CD; Clark LL; Stroud RE; Corn WC; Finklea L; Zile MR; Spinale FG
    Circulation; 2006 Sep; 114(10):1020-7. PubMed ID: 16923753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.